Guggenheim Maintains Buy on GeneDx Holdings, Lowers Price Target to $100
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $170 to $100.
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $170 to $100.